Baay MF - Search Results

1

Can cervical cancer screening be stopped at 50? The prevalence of HPV in elderly women.

Baay MF, Smits E, Tjalma WA, Lardon F, Weyler J, Van Royen P, Van Marck EA, Vermorken JB. Baay MF, et al. Int J Cancer. 2004 Jan 10;108(2):258-61. doi: 10.1002/ijc.11543. Int J Cancer. 2004. PMID: 14639612

2

The value of human papillomavirus detection in primary cervical cancer screening.

Baay MF, Weyler J, Vermorken JB. Baay MF, et al. Eur J Gynaecol Oncol. 2004;25(6):665-9. Eur J Gynaecol Oncol. 2004. PMID: 15597839 Review.

3

Risk factors for cervical cancer development: what do women think?

Baay MF, Verhoeven V, Avonts D, Vermorken JB. Baay MF, et al. Sex Health. 2004;1(3):145-9. doi: 10.1071/sh04004. Sex Health. 2004. PMID: 16335302

4

Microsatellite instability and HPV genotype in Polish women with cervical cancer.

Baay MF, Nakonieczny M, Wozniak I, Deschoolmeester V, Liss J, Lukaszuk K, Sotlar K, Emerich J, Vermorken JB. Baay MF, et al. Eur J Gynaecol Oncol. 2009;30(2):162-6. Eur J Gynaecol Oncol. 2009. PMID: 19480245

5

The prevalence of the human papillomavirus in cervix and vagina in low-risk and high-risk populations.

Baay M, Verhoeven V, Wouters K, Lardon F, Van Damme P, Avonts D, Van Marck E, Van Royen P, Vermorken JB. Baay M, et al. Scand J Infect Dis. 2004;36(6-7):456-9. doi: 10.1080/00365540410020677. Scand J Infect Dis. 2004. PMID: 15307568

6

Detection of HPV and the role of p16INK4A overexpression as a surrogate marker for the presence of functional HPV oncoprotein E7 in colorectal cancer.

Deschoolmeester V, Van Marck V, Baay M, Weyn C, Vermeulen P, Van Marck E, Lardon F, Fontaine V, Vermorken JB. Deschoolmeester V, et al. BMC Cancer. 2010 Mar 26;10:117. doi: 10.1186/1471-2407-10-117. BMC Cancer. 2010. PMID: 20346145 Free PMC article.

7

Probiotics enhance the clearance of human papillomavirus-related cervical lesions: a prospective controlled pilot study.

Verhoeven V, Renard N, Makar A, Van Royen P, Bogers JP, Lardon F, Peeters M, Baay M. Verhoeven V, et al. Eur J Cancer Prev. 2013 Jan;22(1):46-51. doi: 10.1097/CEJ.0b013e328355ed23. Eur J Cancer Prev. 2013. PMID: 22706167 Clinical Trial.

8

Combined Pap and HPV testing in primary screening for cervical abnormalities: should HPV detection be delayed until age 35?

Baay MF, Tjalma WA, Lambrechts HA, Pattyn GG, Lardon F, Weyler J, Van Royen P, Van Marck EA, Vermorken JB. Baay MF, et al. Eur J Cancer. 2005 Nov;41(17):2704-8. doi: 10.1016/j.ejca.2005.04.050. Epub 2005 Oct 18. Eur J Cancer. 2005. PMID: 16242316

9

Everything you always wanted to know about HPV (but could not ask your doctor).

Verhoeven V, Baay MF, Baay PE, Lardon F, Van Royen P, Vermorken JB. Verhoeven V, et al. Among authors: baay mf. Patient Educ Couns. 2010 Oct;81(1):101-5. doi: 10.1016/j.pec.2009.12.006. Epub 2010 Jan 6. Patient Educ Couns. 2010. PMID: 20056371

10

The presence of Y chromosomal deoxyribonucleic acid in the female vaginal swab: possible implications for human papillomavirus testing.

Baay MF, Francois K, Lardon F, Van Royen P, Pauwels P, Vermorken JB, Peeters M, Verhoeven V. Baay MF, et al. Cancer Epidemiol. 2011 Feb;35(1):101-3. doi: 10.1016/j.canep.2010.10.005. Epub 2010 Nov 20. Cancer Epidemiol. 2011. PMID: 21095173

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

82 results

Search Page

Filters